Jim Mel­lon's Ju­ve­nes­cence takes a chance on tiny up­start run by for­mer Pfiz­er ex­ec

When Mar­garet Jack­son was do­ing some con­sult­ing work for Ju­ve­nes­cence CEO Greg Bai­ley last year, she did not an­tic­i­pate the an­ti-ag­ing biotech ven­ture would even­tu­al­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.